show episodes
 
Artwork

1
The Dime

Bryan Fields & Kellan Finney

Unsubscribe
Unsubscribe
Chaque semaine
 
Bryan and Kellan are curious learners, who explore the creative strategies of entrepreneurs pioneering the cannabis industry, projected to reach a $100 billion valuation by 2023. Each week, we dive into guests' journeys, from CEOs of publicly traded giants and world-renowned scientists to underground legacy growers shaping the industry. Discover how they found their place in Cannabis, their original business plans, and the pivots and perseverance needed to navigate cannabis-specific challeng ...
  continue reading
 
Artwork

1
Shared Lunch

Sharesies

Unsubscribe
Unsubscribe
Chaque semaine+
 
A conversation with experts, CEOs, and you. We talk to company leaders and an industry experts every week. Listen or watch over lunch or whenever you want to snack on what’s happening in the economy, the markets, and the companies you invest in Brought to you by Sharesies, with BusinessDesk. Shared Lunch is not financial advice. We recommend talking to a licensed financial adviser. You should review relevant product disclosure documents before deciding to invest. Investing involves risk. You ...
  continue reading
 
Artwork

1
Cannabusiness Solutions

Cannabis Radio

Unsubscribe
Unsubscribe
Chaque mois
 
Teaching Canna-Business owners how to effectively manage all aspects of their business, increase profits and get results. Our expert host Kenneth Burke coaches you on the "do's and don'ts" of running your canna-business, with insight, advice and war stories from the trenches from established leaders in the cannabis industry.
  continue reading
 
Loading …
show series
 
Kentucky is now hot on the radar as a prime location for medical cannabis opportunities. As the application window dwindles, we take a detailed look at the potential and challenges within the state's medical market. In this episode, we explore the intricate process of applying for cannabis licenses in Kentucky. Learn what you need to do to be succe…
  continue reading
 
As Rocket Lab makes history shipping twin spacecraft for NASA’s Mars mission, we catch up with company founder and CEO Sir Peter Beck. Our conversation at Rocket Lab’s Auckland site, follows a June-quarter revenue jump of 70%, and is in anticipation of its Neutron rocket launch in 2025, which the company says will end the SpaceX monopoly for medium…
  continue reading
 
In this quick bite from Shared Lunch, host Helen Matterson and financial advisor Hannah McQueen from Enable.Me tackle a common financial dilemma: how might you balance KiwiSaver contributions and paying off your mortgage? Hannah shares her options on balancing retirement savings with property investment, contributing up to an employer's match, and …
  continue reading
 
Cannabis reform always feels like it's on the verge of a breakthrough with policy. We know some policies can pass both the House & Senate yet it doesn’t , but it ends up feeling like a pawn in the horse trading by policymakers who all know that ~70% of Americans are in favor of cannabis legalization. So why does policy that has support from both si…
  continue reading
 
The cut in the official cash rate to 5.25% is a huge relief for mortgage holders and businesses. We talk to Kiwibank Chief Economist Jarrod Kerr about the significance of this move. Where is inflation at? Will there be further cuts in quick succession or a slow burn? What does this mean for house prices? Don’t miss this short episode for all the an…
  continue reading
 
How do you get ahead once you’ve emptied your savings and most of your Kiwisaver to buy a home? For many of us the financial struggle seems never ending. In keeping with the theme of Sorted Money Month, ‘Pause, get sorted’, we look at what you can do to keep building your wealth for the future. We’re joined by enable.me founder Hannah McQueen who s…
  continue reading
 
Successful marketing requires a blend of specialized expertise and a broad understanding of strategic frameworks. However, too often, marketing gets pigeonholed into a single person's role, expecting them to handle everything from strategy to execution. In fast-paced, scaling startups, this is precisely where fractional marketers can make a critica…
  continue reading
 
We go onsite at Fisher & Paykel's East Tamaki campus and talk to Managing Director Lewis Gradon about his 41 year tenure, and how do you plan for the next 30? The conversation covers recent challenges like the tail from COVID-19, and being disciplined enough not to succumb to short-term share market pressures. Plus the potential anesthesia market, …
  continue reading
 
In this quick bite, Dan Brunskill talks with Damian Spring, CEO of Santana Minerals, as it examines the economic potential of the new gold mine in Otago, New Zealand. What’s Santana’s thinking on where the gold price might go and how has the company scoped the viability if the price drops? Plus, we had to ask about Bitcoin, a so-called digital gold…
  continue reading
 
"Every time a company doubles in size, you need to redo all processes." – Reid Hoffman, founder of LinkedIn. The speed and development of the cannabis industry often conflict with the ability to take a step back and recognize the internal organizational changes that have occurred since the last time you aligned your structure. Are your total compen…
  continue reading
 
What does going for gold look like? No, not the Olympics but a conversation about the potential and the challenges with the gold discovery near Queenstown by newly listed NZX company Santana Minerals. Santana CEO Damian Spring explains the road ahead including the need to raise capital, the journey to get consent—including fast track legislation— a…
  continue reading
 
Cannabis sentiment is not positive enough. Given the challenges and fatigue, it's easy to lose sight of what's happening. Cannabis is being built from the ground up. Regulations and capital may currently hinder some aspects, but what's happening in the industry is undeniable. This week, we sit down with Ben Burstein, who reveals the actual situatio…
  continue reading
 
The medicinal cannabis market has been a long, hard road for NZ players and the patience of retail investors is wearing thin. We talk to Ruatoria based Rua Bioscience about why it's pinning its hopes on a pivot from cultivation and manufacturing, to selling cannabis genetics overseas. Rua CEO Paul Naske sees significant growth as new legal framewor…
  continue reading
 
In this bonus episode to celebrate the launch of Sharesies AI Search, Sharesies co-CEO Sonya Williams talks toTelescope AI CEO Luke Pettit and our own CTO Richard Clark about how artificial intelligence can be applied to investing. The conversation covers recent breakthroughs that have propelled AI into the mainstream like GPT-4, how businesses nee…
  continue reading
 
Tradeshows are a universal way of connecting with others in a similar industry for a unified reason. However, as costs rise, the value of attending these events is weighed against other efforts. Success at these events varies per individual, adding to the challenges. Rama Mayo and the team at Hall of Flowers already have a must-attend event. This y…
  continue reading
 
If you have more than $15,000 and no will, it could be time to sort your life admin. It’s Wills Week 2024 and we look at the perils of not having will, but also the growing trend of leaving something to a cause you’re passionate about. Our conversation with Public Trust wills expert Catherine Simpson busts myths about wills and charitable giving. W…
  continue reading
 
Coming up this Thursday on Shared Lunch we speak with Catherine Simpson from Public Trust about Wills Week 2024. In this quick bite: Why do you need a will & what happens to your estate and investments when you don't have one? In our upcoming episode we also delve into charitable giving and the average amount passed on. Stay tuned for the full epis…
  continue reading
 
While many have found cannabis to be helpful for sleep, is it anecdotal, or is there science to back up these feelings? In the US, 50 to 70 million adults have chronic sleep problems or sleep disorders, according to SleepHealth.org. FloraWorks set out to validate these claims through double-blind placebo trials, employing the rigorous standards use…
  continue reading
 
Is an interest rate cut next? Have we had enough pain? We put these questions and more to Infometrics Principal Economist Brad Olsen after the Reserve Bank held the Official Cash Rate at 5.5% for the eighth time in a row. In this short episode we discuss if November will bring the change mortgage holders and businesses are hoping for. Plus whether …
  continue reading
 
In this quick bite, we dive deep into the world of offshore investing for New Zealanders. Mark Lash from Deloitte Private breaks down the complexities of the Foreign Investment Fund (FIF) regime, explaining: The threshold for FIF rules Special exemptions for Australian investments Fair Dividend Rate vs Comparative Value When to call in the professi…
  continue reading
 
Is tax something you dread or would rather avoid? We’ve got you covered. We ask common questions and chat about what you need to know about your tax as a retail investor. Mark Lash, a partner with Deloitte Private, helps demystify some of that pesky jargon and breaks down the what, when and how of tax when investing in company shares and funds. Thi…
  continue reading
 
In this quick bite: Chris Di Leva from Harbour Asset Management discusses the surprising performance of the Japanese stock market with host Dan Brunskill. Did you know Japan's market hit an all-time high in 2024, matching its 1989 peak? Chris explains the 35-year journey of zero nominal returns and recent reforms driving Japan's market rally. Plus,…
  continue reading
 
The lack of guidance from the US Federal Government on the cannabinoid industry poses significant challenges for those involved in the sector. The absence of clear regulations and leadership complicates business operations. In contrast, European countries are both legalizing cannabis and planning further legalization. They are keen to avoid the mis…
  continue reading
 
Why invest locally when the action appears to be in the US? The meteoric rise of US chipmaker NVIDIA and the dominance of high earning tech stocks makes it hard for the likes of the NZX and ASX to compete. We talk to Harbour Asset Management’s Chris di Leva about how the sector make-up of an index and the local economy are a huge influence. But als…
  continue reading
 
In this quick bite: Todd Dawson, CEO of Napier Port, discusses the vital role of ports in New Zealand's economy. Did you know 90% of the country's exports and imports travel by sea? Plus what are the revenue streams for a port? Eg: container trade, bulk trade (primarily logs), and the growing cruise industry. This quick bite is from our previous ep…
  continue reading
 
Creating a powerful and emotionally resonant message is essential in the cannabis industry, where many people have unique and personal connections to the plant. Crafting a message that genuinely resonates can yield compounding results. Although PR and marketing often get grouped together, they require distinct strategies to complement each other ef…
  continue reading
 
Ports are critical to our island nation given more than 90% of our exports and imports travel by sea. Our conversation with Napier Port CEO Todd Dawson explores how a traditional business has embraced tech and supply chain logistics. You’ll find out the benefits of a public-private partnership model (including employees with skin in the game), how …
  continue reading
 
In this quick bite we talk to Dr Deborah Lambie, global equity analyst at Milford Asset Management, about how cutting-edge technologies like AI-driven molecular design, accelerated simulations, and the concept of "self-driving labs" are enabling companies to develop new medicines up to 10 times faster and at significantly lower costs. Plus, we expl…
  continue reading
 
What does your business do better than anyone else's? This is your competitive advantage. As we move away from the "growth at all costs" mindset, businesses are doubling down on their strengths—Grown Rogue has emphatically done just that. Battle-tested in highly competitive markets, this high-end cultivator consistently proves its ability to design…
  continue reading
 
US big pharma, including Ozempic maker Novo Nordisk, continue to make huge gains from the new generation of obesity drugs. But how do investors weigh up the potential of this industry? We talk to Dr Deborah Lambie, global equity analyst at Milford Asset Management, about why these drugs have captured the world and the eye watering share price gains…
  continue reading
 
In this quick bite: Infratil CEO Jason Boyes reflects on why it’s important for the infrastructure company to not only grow globally, but still appeal to the hearts and minds of NZers. For more or to watch on youtube—check out http://linktr.ee/sharedlunch Brought to you by Sharesies, with BusinessDesk. Appearance on Shared Lunch is not an endorseme…
  continue reading
 
New York's Cannabis Program can only be described one way: Broken. Despite lessons learned from other states and a goal to help those previously harmed, the program has faced significant financial and operational challenges, falling short of its intended success. With government officials labeling the rollout a disaster and promising an overhaul, t…
  continue reading
 
What’s next for the market darling infrastructure investment company infratil? Can it maintain double digit growth? We talk to Infratil CEO Jason Boyes as the company reflects on 30 years and its $14 billion portfolio of 15 companies across four sectors—digital, renewables, healthcare and airports. Off the back of Infrail’s full year results and ou…
  continue reading
 
In this quick bite, Tony Alexander looks at current downturn in New Zealand's housing market, delving into the surge of listings and the emerging trend of investors offloading properties. Plus the big question, when will the market recover? For more or to watch on youtube—check out http://linktr.ee/sharedlunch Brought to you by Sharesies, with Busi…
  continue reading
 
Public companies dominate the headlines for the cannabis industry, but a few private beasts operate in plain sight. Motif Labs is one of them. Their deep focus on profitability and data at every step is why they have built such a deeply rooted and successful organizational philosophy. This week, we sit down with Mario Naric to discuss: How he build…
  continue reading
 
A sharp increase in house listings as some long-time investors exit, has put the ball back in the buyer's court. We talk to independent economist Tony Alexander about his analysis on this and the latest results from the quarterly Sharesies Investing Insights survey. You'll hear his prediction on when interest rate cuts will start, why house prices …
  continue reading
 
EROAD has 120,000 devices in cars in New Zealand and is making inroads in the US. What’s the potential of this data combined with the latest in AI development? We find out in this bonus episode featuring EROAD co-CEOs Mark Heine and David Kenneson following the company’s recent financial results. Our conversation covers technology, privacy and futu…
  continue reading
 
Pricing and promotion in the retail business may seem closely linked but are fundamentally different. Understanding the intention behind a promotion across the organization is a critical yet often overlooked element in the cannabis industry. Using pricing as a tool to drive sales can have unintended consequences. For example, if a customer typicall…
  continue reading
 
The transition to net-zero has put NZ founded tech company Gentrack on the investor map. We talk to CEO Gary Miles off the back of some impressive half-year results and as Gentrack expands into the Middle East, Asia and Europe with its software that includes smart metering, sensors and billing for power and water utilities, and airports. You’ll lea…
  continue reading
 
In a landscape of fluctuating interest rates, where are you parking your cash? Economist Brad Olsen breaks down the current financial environment and we ask what decisions are facing savers and borrowers? Plus, the emerging trend of shorter fixed mortgage terms... This is from our previous episode 'When will interest rates turn? Brad’s view' For mo…
  continue reading
 
Synthesis, a process that may sound complex, is actually quite common in our daily lives. From the production of everyday items like Advil, organic milk, citric acid, to the creation of vitamins A and D, and multivitamins, synthesis is a key player. Why does this realization often provoke a negative reaction? Perhaps it's because there's a desire f…
  continue reading
 
The economy has been a bleak subject for much of this year. But are we starting to see that light at the end of the tunnel? For a pulse check we talk to Infometrics Principal Economist Brad Olsen about how NZ is faring and what makes our situation different to other parts of the world. Unsurprisingly the higher interest rate environment dominates o…
  continue reading
 
In this bonus bite, Frances Cook & Milford's Daniel Wu dive into Meta's (Facebook's) planned use of AI and the potential to leverage its massive user data trove. We explore how Meta might responsibly use this data for other purposes, such as training AI models, while addressing privacy concerns. Join us as we discuss Meta's AI ambitions, the challe…
  continue reading
 
The economic impact of Hop Latent Viroid on cannabis cultivation remains a significant concern, costing the industry millions annually. In our latest episode, we dive into proactive measures to combat this threat with Dr. Tassa Saldi. Affecting ~80% of cultivators, Dr. Saldi sheds light on the necessity of proactively testing. While some may questi…
  continue reading
 
What’s next for Meta, the tech titan behind brands like Facebook, Instagram and WhatsApp? Sydney based Milford Asset Management senior analyst, David Wu, covers all the bases following Meta’s Q1 earnings, including why its forward guidance disappointed some investors. This conversation looks at the potential and the challenges ahead for Meta includ…
  continue reading
 
We cross to Omaha, Nebraska in the US to speak with Sharesies co-founder and CEO Leighton Roberts as he fulfills a life-long dream to hear investing legend Warren Buffet. Leighton was one of 40,000+ investors from all over the world who attended the Berkshire Hathaway annual shareholder meeting. Helen Matterson asks Leighton about the experience an…
  continue reading
 
BRĒZ immediate success is a testament to the power of a skilled team, a great product, and incredible marketing. A little over a year since its inception, BRĒZ hockey stick trajectory is undeniable and worthy of emulation. When executed perfectly, marketing becomes more than just a line item on a P&L; it becomes a tool with unlimited potential. BRĒ…
  continue reading
 
Ever seen a small ‘B’ logo on a product or website? You were probably looking at a certified B Corporation—a business that meets rigorous standards of social and environmental performance. Sharesies co-founder and co-CEO Brooke Roberts sits down with Alex Hannant and Mindy Leow from B Lab—the nonprofit network behind B Corp certifications—to discus…
  continue reading
 
Last week on Shared Lunch James Shaw, former Climate Change Minister, joined Pattrick Smellie to talk climate investment. In this quick bite he shares how he sees the global transition to sustainable technologies as one of the most significant investment opportunities we’ve faced, spanning infrastructure, housing, transport, energy, waste managemen…
  continue reading
 
The use of psychedelics by high-performing individuals and entrepreneurs is on the rise as they openly discuss the benefits these substances offer. As research continues and we dive deeper into these advantages, questions arise: Where are the opportunities, and what should interested individuals know? How do they get started, and how do they find t…
  continue reading
 
Loading …

Guide de référence rapide